Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 4
2022 6
2023 3
2024 5
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial.
Patel VC, Lee S, McPhail MJW, Da Silva K, Guilly S, Zamalloa A, Witherden E, Støy S, Manakkat Vijay GK, Pons N, Galleron N, Huang X, Gencer S, Coen M, Tranah TH, Wendon JA, Bruce KD, Le Chatelier E, Ehrlich SD, Edwards LA, Shoaie S, Shawcross DL. Patel VC, et al. Among authors: zamalloa a. J Hepatol. 2022 Feb;76(2):332-342. doi: 10.1016/j.jhep.2021.09.010. Epub 2021 Sep 24. J Hepatol. 2022. PMID: 34571050 Free article. Clinical Trial.
Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial.
Patel VC, McPhail MJ, Uddin R, Jafari H, Lawrence V, Le Boutillier C, Shearer J, Yaziji N, Cape A, Ahmed H, Ward C, Walsh P, Besly K, Zamalloa A, Kelly J; BOPPP study group; Carter B. Patel VC, et al. Among authors: zamalloa a. Trials. 2024 Apr 16;25(1):265. doi: 10.1186/s13063-024-08063-3. Trials. 2024. PMID: 38627804 Free PMC article.
Patient-derived precision cut tissue slices from primary liver cancer as a potential platform for preclinical drug testing.
Jagatia R, Doornebal EJ, Rastovic U, Harris N, Feyide M, Lyons AM, Miquel R, Zen Y, Zamalloa A, Malik F, Prachalias A, Menon K, Boulter L, Eaton S, Heaton N, Phillips S, Chokshi S, Palma E. Jagatia R, et al. Among authors: zamalloa a. EBioMedicine. 2023 Nov;97:104826. doi: 10.1016/j.ebiom.2023.104826. Epub 2023 Oct 10. EBioMedicine. 2023. PMID: 37806285 Free PMC article.
Oral-gut microbiome interactions in advanced cirrhosis: characterisation of pathogenic enterotypes and salivatypes, virulence factors and antimicrobial resistance.
Lee S, Arefaine B, Begum N, Stamouli M, Witherden E, Mohamad M, Harzandi A, Zamalloa A, Cai H, Williams R, Curtis MA, Edwards LA, Chokshi S, Mardinoglu A, Proctor G, Moyes DL, McPhail MJ, Shawcross DL, Uhlen M, Shoaie S, Patel VC. Lee S, et al. Among authors: zamalloa a. J Hepatol. 2025 Apr;82(4):622-633. doi: 10.1016/j.jhep.2024.09.046. Epub 2024 Oct 22. J Hepatol. 2025. PMID: 39447963 Free article.
Human Immunocompetent Model of Neuroendocrine Liver Metastases Recapitulates Patient-Specific Tumour Microenvironment.
Doornebal EJ, Harris N, Riva A, Jagatia R, Pizanias M, Prachalias A, Menon K, Preziosi M, Zamalloa A, Miquel R, Zen Y, Orford MR, Eaton S, Heaton N, Ramage J, Palma E, Srirajaskanthan R, Chokshi S. Doornebal EJ, et al. Among authors: zamalloa a. Front Endocrinol (Lausanne). 2022 Jul 13;13:909180. doi: 10.3389/fendo.2022.909180. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35909511 Free PMC article.
Intracellular and extracellular activities of V-domain Ig-containing suppressor of T cell activation (VISTA) modulated by immunosuppressive factors of tumour microenvironment.
Abooali M, Schlichtner S, Lei X, Aliu N, Ruggiero S, Loges S, Ziegler M, Hertel F, Volckmar AL, Stenzinger A, Christopoulos P, Thomas M, Klenova E, Meyer NH, Boussios S, Heaton N, Zen Y, Zamalloa A, Chokshi S, Urbani L, Richard S, Kirubendran K, Hussain R, Siligardi G, Cholewa D, Berger SM, Yasinska IM, Fasler-Kan E, Sumbayev VV. Abooali M, et al. Among authors: zamalloa a. Cancer Lett. 2025 Apr 28;616:217581. doi: 10.1016/j.canlet.2025.217581. Epub 2025 Feb 20. Cancer Lett. 2025. PMID: 39983894 Free article.
Using a theory-informed approach to explore patient and staff perspectives on factors that influence clinical trial recruitment for patients with cirrhosis and small oesophageal varices.
Le Boutillier C, Snowdon C, Patel V, McPhail M, Ward C, Carter B, Uddin R, Zamalloa A, Lawrence V. Le Boutillier C, et al. Among authors: zamalloa a. PLoS One. 2022 Feb 3;17(2):e0263288. doi: 10.1371/journal.pone.0263288. eCollection 2022. PLoS One. 2022. PMID: 35113923 Free PMC article. Clinical Trial.
18 results